Literature DB >> 33472232

En Bloc AngioVac Removal of Thoracic Aortic Mass.

Jeanney Kang1, Fernando Fleischman2, Farhood Saremi3, David M Shavelle4.   

Abstract

The AngioVac system, designed for suction during extracorporeal bypass, is used to aspirate masses, thrombi, and other undesirable material from the cardiovascular system. To date, it has been used extensively in the venous system and right side of the heart; however, its use in the arterial system has been limited because of smaller vessel sizes and the requirement for a 26F sheath. We report the case of a 45-year-old woman with a history of angiosarcoma who presented with acute embolic events that affected her spleen and lower extremities. We removed a large mobile mass en bloc from her distal thoracic aorta by using the AngioVac system as an alternative to surgical resection. The patient recovered with no recurrence. We discuss the benefits and challenges of using the AngioVac within small vessels of the arterial system.
© 2020 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Arterial occlusive diseases/therapy; equipment design; heart diseases/therapy; mechanical thrombolysis/instrumentation/methods; suction/instrumentation; thrombectomy/methods/therapy; treatment outcome; vascular access devices

Mesh:

Year:  2020        PMID: 33472232      PMCID: PMC7819443          DOI: 10.14503/THIJ-18-6917

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  16 in total

1.  AngioVac Removal of a Saddle Pulmonary Embolus Using TEE Guidance and Venoarterial ECMO Support.

Authors:  Johnathan R Renew; Erica D Wittwer; Tiffany M Robb; Maria D Fritock
Journal:  J Cardiothorac Vasc Anesth       Date:  2015-10-17       Impact factor: 2.628

Review 2.  Role of Cardiac CT Before Transcatheter Aortic Valve Implantation (TAVI).

Authors:  Mohamed Marwan; Stephan Achenbach
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

3.  Percutaneous extraction of right atrial mass using the Angiovac aspiration system.

Authors:  Thomas M Todoran; Piotr S Sobieszczyk; Michael S Levy; Tjorvi E Perry; Douglas C Shook; Scott Kinlay; Michael J Davidson; Andrew C Eisenhauer
Journal:  J Vasc Interv Radiol       Date:  2011-09       Impact factor: 3.464

4.  A novel approach in the management of right-sided endocarditis: percutaneous vegectomy using the AngioVac cannula.

Authors:  Ashwin K Thiagaraj; Meenal Malviya; Wah W Htun; Tesfaye Telila; Stephen A Lerner; Mahir D Elder; Theodore L Schreiber
Journal:  Future Cardiol       Date:  2017-03-22

5.  Novel use of the AngioVac® system to remove thrombus during simultaneous extracorporeal membrane oxygenation life support.

Authors:  Kevin E Griffith; Eric Jenkins; William Copenhaver; David M Williams
Journal:  Perfusion       Date:  2015-06-01       Impact factor: 1.972

Review 6.  Percutaneous Embolectomy of Serpentine Thrombus from the Right Atrium in a 51-Year-Old Man.

Authors:  Soumya Patnaik; Harish Seetha Rammohan; Mahek Shah; Shivani Garg; Vincent Figueredo; Sean Janzer; Salil Shah
Journal:  Tex Heart Inst J       Date:  2016-12-01

7.  Percutaneous Removal of Filter-Induced Iliocaval Thrombus Using the AngioVac Device.

Authors:  Berhane Worku; Kyle Blake; Iosif Gulkarov; Akhilesh Sista; Arash Salemi
Journal:  Innovations (Phila)       Date:  2015 May-Jun

8.  The Use of AngioVac for Symptomatic Aortic Thrombus Complicated by Mesenteric Ischemia.

Authors:  Spyridon Monastiriotis; Carl Gonzales; Angela Kokkosis; Nicos Labropoulos; Thomas Bilfinger; Apostolos K Tassiopoulos
Journal:  Ann Vasc Surg       Date:  2016-01-22       Impact factor: 1.466

9.  Removal of Caval and Right Atrial Thrombi and Masses Using the AngioVac Device: Initial Operative Experience.

Authors:  John M Moriarty; Ramsey Al-Hakim; Anshuman Bansal; Jonathan K Park
Journal:  J Vasc Interv Radiol       Date:  2016-06-06       Impact factor: 3.464

10.  Use of internal endoconduits as an adjunct to endovascular aneurysm repair in the setting of challenging aortoiliac anatomy.

Authors:  Timothy Wu; John G Carson; Christopher L Skelly
Journal:  Ann Vasc Surg       Date:  2009-09-11       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.